| Treatment of nephrotic syndrome associated with idiopathic rapidly progressive glomerulonephritis and cyclosporin A. | |
| | |
MedLine Citation:
|
PMID: 8473362 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent reports suggest that cyclosporin A is beneficial in inducing remission of idiopathic nephrotic syndrome. Nephrotic syndrome is seen in 10-30% of patients with rapidly progressive glomerulonephritis. We report a case of a 69-year-old man with nephrotic syndrome, associated with idiopathic rapidly progressive glomerulonephritis, who was treated initially with corticosteroid and cyclophosphamide. Three months later he developed thrombophlebitis and leucopenia and cyclophosphamide was suspended. Relapse of nephrotic syndrome associated with rapidly progressive glomerulonephritis developed and therapy with cyclosporin A was used with a good response. |
| | |
Authors:
|
F Maduell; A Sánchez-Alcaraz; F Sigüenza; A Caridad; G Sangrador |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of clinical pharmacy and therapeutics Volume: 18 ISSN: 0269-4727 ISO Abbreviation: J Clin Pharm Ther Publication Date: 1993 Feb |
Date Detail:
|
Created Date: 1993-05-20 Completed Date: 1993-05-20 Revised Date: 2008-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 8704308 Medline TA: J Clin Pharm Ther Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 59-62 Citation Subset: IM |
Affiliation:
|
Department of Pharmaceutical Services, Lluis Alcanyis Hospital, Xàtiva, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Aged Cyclosporine / administration & dosage, therapeutic use* Glomerulonephritis / complications* Humans Male Nephrotic Syndrome / drug therapy*, etiology |
| Chemical | |
Reg. No./Substance:
|
59865-13-3/Cyclosporine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estimation of population pharmacokinetics for carbamazepine in Malaysian patients using the OPT comp...
Next Document: Digoxin pharmacokinetics in patients with high serum digoxin concentrations.